Institut Sainte-Catherine; Oncologie

Avignon 84082

0 studies enrolling now · 1 studies all time

What they study most

Prostatic Neoplasms, Castration-Resistant

Studies at this site

• A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen — Completed